TEAD4 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant TEAD4.
|Application ||WB, IP, E|
|Calculated MW||48329 Da|
|Other Names||Transcriptional enhancer factor TEF-3, TEA domain family member 4, TEAD-4, Transcription factor 13-like 1, Transcription factor RTEF-1, TEAD4, RTEF1, TCF13L1, TEF3|
|Target/Specificity||TEAD4 (NP_003204, 151 a.a. ~ 260 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||TEAD4 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
This gene product is a member of the transcriptional enhancer factor (TEF) family of transcription factors, which contain the TEA/ATTS DNA-binding domain. It is preferentially expressed in the skeletal muscle, and binds to the M-CAT regulatory element found in promoters of muscle-specific genes to direct their gene expression. Alternatively spliced transcripts encoding distinct isoforms, some of which are translated through the use of a non-AUG (UUG) initiation codon, have been described for this gene.
1.Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer.Lim B, Park JL, Kim HJ, Park YK, Kim JH, Sohn HA, Noh SM, Song KS, Kim WH, Kim YS, Kim SYCarcinogenesis. 2013 Dec 31.2.Induction of a trophoblast-like phenotype by hydralazine in the p19 embryonic carcinoma cell line.O'Driscoll CM, Coulter JB, Bressler JP.Biochim Biophys Acta. 2012 Nov 26. pii: S0167-4889(12)00333-3. doi: 10.1016/j.bbamcr.2012.11.012.3.Transcription factor TEAD4 regulates expression of Myogenin and the unfolded protein response genes during C2C12 cell differentiation.Benhaddou A, Keime C, Ye T, Morlon A, Michel I, Jost B, Mengus G, Davidson I.Cell Death Differ. 2011 Jun 24. doi: 10.1038/cdd.2011.87.
If you have any additional inquiries please email technical services at email@example.com.